11/12/2024
12:44 PM | AdvisorShares Trust (Filed by)
InMed Pharmaceuticals (Subject)
| Form SC 13G | |
11/05/2024
8:08 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
3:50 PM | InMed Pharmaceuticals (Filer)
| Form DEF 14A | |
10/28/2024
3:00 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
2:25 PM | InMed Pharmaceuticals (Filer)
| Form DEFA14A | |
10/24/2024
2:57 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2024
11:28 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/17/2024
5:30 AM | InMed Pharmaceuticals (Filer)
| Form 424B3 | |
09/30/2024
12:37 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
3:10 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2024
1:04 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
1:00 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
2:08 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
7:32 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
11:48 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
3:26 PM | HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
12:30 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
1:39 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
10:26 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
12:44 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
2:20 PM | InMed Pharmaceuticals (Issuer)
MANCINI ALEXANDRA DIANE JANET (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
2:20 PM | HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
2:20 PM | HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
2:27 PM | InMed Pharmaceuticals (Issuer)
Jagpal Netta (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/22/2024
12:38 PM | HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
1:58 PM | ADAMS ERIC A (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
1:28 PM | ARMISTICE CAPITAL, LLC (Filed by)
InMed Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
11:34 AM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
1:33 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
1:12 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
12:04 PM | HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
12:04 PM | InMed Pharmaceuticals (Issuer)
MANCINI ALEXANDRA DIANE JANET (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
12:05 PM | Baldasare Bryan T (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
12:07 PM | ADAMS ERIC A (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
12:07 PM | HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
12:08 PM | Grove Janet P (Reporting)
InMed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
12:08 PM | InMed Pharmaceuticals (Issuer)
Tegge Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
12:09 PM | InMed Pharmaceuticals (Issuer)
WOUDENBERG MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
12:09 PM | InMed Pharmaceuticals (Issuer)
Lemerond Nicole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
12:09 PM | InMed Pharmaceuticals (Issuer)
Johnson Shane Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
4:21 PM | InMed Pharmaceuticals (Filer)
| Form 10-K/A | |
9 hidden AI stocks set to thrive in Trump’s new era (Ad) AI ETFs are Booming, But These 9 AI Stocks are Better Plays
By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth) Get the Name of These AI Picks Now |
12/06/2023
8:02 AM | InMed Pharmaceuticals (Issuer)
WOUDENBERG MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
1:50 PM | InMed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
